Viewpoint Clinical Conference
Zug, Switzerland

Michael Mrochen

Doctor of Theoretical Medicine

Zug, Switzerland

Biography

Over the past 25 years, Michael Mrochen has founded, led and worked with companies that have developed and commercialised multiple innovative ophthalmic technologies and procedures with impact.

As an Engineer in Physics, Doctor of Theoretical Medicine and Entrepreneur in the ophthalmic and vision care industries with a large network, Michael is working to bridge the technical, clinical, and commercial worlds together to achieve meaningful outcomes. In this role, he has repeatedly succeeded in developing and deploying revolutionary products to the market that have improved the lives of countless patients worldwide.

Michael has extensive experience working with start-ups, medium size corporates and the largest multinational companies in the industry. Currently, he is a member of the board of a range of ophthalmic companies in addition to directing technology development at Allotex. He has also lectured at ETH Zurich for 15 years, published over 120 articles, reports, and book chapters in the field of ophthalmology and ophthalmic technology and have generated over 50 patents and patent applications. Finally, he regularly performs as a keynote speaker at ophthalmology events around the world.

Biography

Over the past 25 years, Michael Mrochen has founded, led and worked with companies that have developed and commercialised multiple innovative ophthalmic technologies and procedures with impact.

As an Engineer in Physics, Doctor of Theoretical Medicine and Entrepreneur in the ophthalmic and vision care industries with a large network, Michael is working to bridge the technical, clinical, and commercial worlds together to achieve meaningful outcomes. In this role, he has repeatedly succeeded in developing and deploying revolutionary products to the market that have improved the lives of countless patients worldwide.

Michael has extensive experience working with start-ups, medium size corporates and the largest multinational companies in the industry. Currently, he is a member of the board of a range of ophthalmic companies in addition to directing technology development at Allotex. He has also lectured at ETH Zurich for 15 years, published over 120 articles, reports, and book chapters in the field of ophthalmology and ophthalmic technology and have generated over 50 patents and patent applications. Finally, he regularly performs as a keynote speaker at ophthalmology events around the world.